|
1
|
Lee AW, Tung SY, Ngan RK, Chappell R, Chua
DT, Lu TX, Siu L, Tan T, Chan LK, Ng WT, et al: Factors
contributing to the efficacy of concurrent-adjuvant chemotherapy
for locoregionally advanced nasopharyngeal carcinoma: Combined
analyses of NPC-9901 and NPC-9902 Trials. Eur J Cancer. 47:656–666.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen Y, Liu MZ, Liang SB, Zong JF, Mao YP,
Tang LL, Guo Y, Lin AH, Zeng XF and Ma J: Preliminary results of a
prospective randomized trial comparing concurrent chemoradiotherapy
plus adjuvant chemotherapy with radiotherapy alone in patients with
locoregionally advanced nasopharyngeal carcinoma in endemic regions
of china. Int J Radiat Oncol Biol Phys. 71:1356–1364. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guo Y, Zhu XD, Qu S, Li L, Su F, Li Y,
Huang ST and Li DR: Identification of genes involved in
radioresistance of nasopharyngeal carcinoma by integrating gene
ontology and protein-protein interaction networks. Int J Oncol.
40:85–92. 2012.PubMed/NCBI
|
|
4
|
Feng XP, Yi H, Li MY, Li XH, Yi B, Zhang
PF, Li C, Peng F, Tang CE, Li JL, et al: Identification of
biomarkers for predicting nasopharyngeal carcinoma response to
radiotherapy by proteomics. Cancer Res. 70:3450–3462. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sekhar KR, Reddy YT, Reddy PN, Crooks PA,
Venkateswaran A, McDonald WH, Geng L, Sasi S, Van Der Waal RP, Roti
JL, et al: The novel chemical entity YTR107 inhibits recruitment of
nucleophosmin to sites of DNA damage, suppressing repair of DNA
double-strand breaks and enhancing radiosensitization. Clin Cancer
Res. 17:6490–6499. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Skvortsova I, Skvortsov S, Stasyk T, Raju
U, Popper BA, Schiestl B, von Guggenberg E, Neher A, Bonn GK, Huber
LA and Lukas P: Intracellular signaling pathways regulating
radioresistance of human prostate carcinoma cells. Proteomics.
8:4521–4533. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim SH, Lee SY, Park HR, Sung JM, Park AR,
Kang S, Kim BG, Choi YP, Kim YB and Cho NH: Nuclear localization of
Nm23-H1 in head and neck squamous cell carcinoma is associated with
radiation resistance. Cancer. 117:1864–1873. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li L, Huang S, Zhu X, Zhou Z, Liu Y, Qu S
and Guo Y: Identification of radioresistance-associated proteins in
human nasopharyngeal carcinoma cell lines by proteomic analysis.
Cancer biother Radiopharm. 28:380–384. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Geddes DM: The natural history of lung
cancer: A review based on rates of tumour growth. Br J Dis Chest.
73:1–17. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chang JT, Chan SH, Lin CY, Lin TY, Wang
HM, Liao CT, Wang TH, Lee LY and Cheng AJ: Differentially expressed
genes in radioresistant nasopharyngeal cancer cells: Gp96 and
GDF15. Mol Cancer Ther. 6:2271–2279. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He F, Luo W, Zhang Q, Guo Y, Liu MZ and Ma
J: Retrospective analysis of effectiveness of intensity-modulated
radiotherapy combined with chemotherapy or not for locoregionally
advanced nasopharyngeal carcinoma. Zhonghua Yi Xue Za Zhi.
93:2292–2295. 2013.(In Chinese). PubMed/NCBI
|
|
12
|
Brady SN, Maggi LB Jr, Winkeler CL, Toso
EA, Gwinn AS, Pelletier CL and Weber JD: Nucleophosmin protein
expression level, but not threonine 198 phosphorylation, is
essential in growth and proliferation. Oncogene. 28:3209–3220.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Koike A, Nishikawa H, Wu W, Okada Y,
Venkitaraman AR and Ohta T: Recruitment of phosphorylated NPM1 to
sites of DNA damage through RNF8-dependent ubiquitin conjugates.
Cancer Res. 70:6746–6756. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Derenzini M, Sirri V, Trerè D and Ochs RL:
The quantity of nucleolar proteins nucleolin and protein B23 is
related to cell doubling time in human cancer cells. Lab Invest.
73:497–502. 1995.PubMed/NCBI
|
|
15
|
Coutinho-Camillo CM, Lourenço SV,
Nishimoto IN, Kowalski LP and Soares FA: Nucleophosmin, p53 and
Ki-67 expression patterns on an oral squamous cell carcinoma tissue
microarray. Hum Pathol. 41:1079–1086. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Grisendi S, Mecucci C, Falini B and
Pandolfi PP: Nucleophosmin and cancer. Nat Rev Cancer. 6:493–505.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gerke V, Creutz CE and Moss SE: Annexins:
Linking Ca2+ signalling to membrane dynamics. Nat Rev
Mol Cell Biol. 6:449–461. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gerke V and Moss SE: Annexins: From
structure to function. Physiol Rev. 82:331–371. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mussunoor S and Murray GI: The role of
annexins in tumour development and progression. J Pathol.
216:131–140. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kollermann J, Schlomm T, Bang H, Schwall
GP, von Eichel-Streiber C, Simon R, Schostak M, Huland H, Berg W,
Sauter G, et al: Expression and prognostic relevance of annexin A3
in prostate cancer. Eur Urol. 54:1314–1323. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu YF, Xiao ZQ, Li MX, Li MY, Zhang PF,
Li C, Li F, Chen YH, Yi H, Yao HX and Chen ZC: Quantitative
proteome analysis reveals annexin A3 as a novel biomarker in lung
adenocarcinoma. J Pathol. 217:54–64. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jung EJ, Moon HG, Park ST, Cho BI, Lee SM,
Jeong CY, Ju YT, Jeong SH, Lee YJ, Choi SK, et al: Decreased
annexin A3 expression correlates with tumor progression in
papillary thyroid cancer. Proteomics Clin Appl. 4:528–537.
2010.PubMed/NCBI
|
|
23
|
Lascu L: The nucleoside diphosphate
kinases 1973–2000. J Bioenerg Biomembr. 32:213–214. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang M, Jarrett SG, Craven R and Kaetzel
DM: YNK1, the yeast homolog of human metastasis suppressor NM23, is
required for repair of UV radiation- and etoposide-induced DNA
damage. Mutat Res. 660:74–78. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jarrett SG, Novak M, Dabernat S, Daniel
JY, Mellon I, Zhang Q, Harris N, Ciesielski MJ, Fenstermaker RA,
Kovacic D, et al: Metastasis suppressor NM23-H1 promotes repair of
UV-induced DNA damage and suppresses UV-induced melanomagenesis.
Cancer Res. 72:133–143. 2012. View Article : Google Scholar : PubMed/NCBI
|
